Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  CEL-SCI Corporation    

 SummaryNewsCalendarCompanyFinancials 
Company
CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases.The company's lead investigational therapy, Multikine is currently in a pivotal phase 3 clinical trial against... 
More about the company
Latest news on CEL-SCI CORPORATION
2016 CEL SCI : Announces Closing of Public Offereing and Receives Audit Opinion with ..
2016 CEL-SCI CORPORATION (NASDAQ : CVM) Files An 8-K Other Events
2016 CEL-SCI CORPORATION (NASDAQ : CSCIW) Files An 8-K Other Events
2016 CEL SCI CORP : Other Events (form 8-K)
2016 CEL SCI : NEW STORY CEL-SCI Announces Closing of Public Offering and Receives Au..
2016 CEL SCI : Announces Closing of Public Offering and Receives Audit Opinion with G..
2016 CEL SCI : Announces Pricing of $4.25 Million Public Offering of Common Stock and..
2016 CEL SCI : NEW STORY CEL-SCI Reports Fiscal 2016 Financial Results and Clinical &..
2016 CEL SCI : reports 4Q loss
2016 CEL SCI : Reports Fiscal 2016 Financial Results and Clinical & Corporate Develop..
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
Advertisement
Managers
NameTitle
Geert R. Kersten CEO, CFO, Treasurer, Director & CAO
Patricia B. Prichep Secretary & Senior Vice President-Operations
Eyal Talor Chief Scientific Officer
Alexander G. Esterhazy Independent Director
Peter R. Young Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CEL-SCI CORPORATION20
AMGEN, INC.4.45%113 612
GILEAD SCIENCES, INC.-1.28%93 131
CELGENE CORPORATION-2.97%87 063
REGENERON PHARMACEUTIC..-3.47%37 374
ACTELION LTD1.18%24 865
More Results